XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Cumulative-effect adjustment
Retained Earnings
Accumulated other comprehensive Income (loss)
Treasury Stock
Cumulative-effect adjustment
Total
Balance, beginning at Dec. 31, 2018 $ 1,397 $ 2,495,853   $ 291,919 $ (132,195) $ (132,135)   $ 2,524,839
Balance (in shares) at Dec. 31, 2018 134,874,302              
Increase (Decrease) in Stockholders' Equity                
Net income       216,556       216,556
Cash dividends declared       (104,392)       (104,392)
Equity-based awards $ 2 5,471   (766)   (1,764)   2,943
Equity-based awards (in shares) 185,736              
Common stock repurchased           (98,809)   (98,809)
Common stock repurchased (in shares) (3,799,138)              
Other comprehensive income, net of tax         113,421     113,421
Balance, ending at Sep. 30, 2019 $ 1,399 2,501,324   403,317 (18,774) (232,708)   2,654,558
Balance (in shares) at Sep. 30, 2019 131,260,900              
Balance, beginning at Jun. 30, 2019 $ 1,399 2,499,946   363,748 (31,984) (173,668)   2,659,441
Balance (in shares) at Jun. 30, 2019 133,508,212              
Increase (Decrease) in Stockholders' Equity                
Net income       74,199       74,199
Cash dividends declared       (34,408)       (34,408)
Equity-based awards   1,378   (222)   (231)   925
Equity-based awards (in shares) 41,980              
Common stock repurchased           (58,809)   (58,809)
Common stock repurchased (in shares) (2,289,292)              
Other comprehensive income, net of tax         13,210     13,210
Balance, ending at Sep. 30, 2019 $ 1,399 2,501,324   403,317 (18,774) (232,708)   2,654,558
Balance (in shares) at Sep. 30, 2019 131,260,900              
Increase (Decrease) in Stockholders' Equity                
Cumulative-effect adjustment of change in accounting principle, net of tax: ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments     $ (12,517)       $ (12,517)  
Balance, beginning at Dec. 31, 2019 $ 1,399 2,503,677   437,072 (31,749) (270,141)   $ 2,640,258
Balance (in shares) at Dec. 31, 2019 129,928,479             129,928,479
Increase (Decrease) in Stockholders' Equity                
Net income       124,015       $ 124,015
Cash dividends declared       (101,322)       (101,322)
Equity-based awards $ 3 8,172   (933)   (1,745)   5,497
Equity-based awards (in shares) 201,069              
Common stock repurchased           (5,000)   (5,000)
Common stock repurchased (in shares) (217,759)              
Other comprehensive income, net of tax         83,003     83,003
Balance, ending at Sep. 30, 2020 $ 1,402 2,511,849   446,315 51,254 (276,886)   $ 2,733,934
Balance (in shares) at Sep. 30, 2020 129,911,789             129,911,789
Balance, beginning at Jun. 30, 2020 $ 1,401 2,509,271   415,296 52,731 (276,802)   $ 2,701,897
Balance (in shares) at Jun. 30, 2020 129,866,898              
Increase (Decrease) in Stockholders' Equity                
Net income       65,101       65,101
Cash dividends declared       (33,775)       (33,775)
Equity-based awards $ 1 2,578   (307)   (84)   2,188
Equity-based awards (in shares) 44,891              
Other comprehensive income, net of tax         (1,477)     (1,477)
Balance, ending at Sep. 30, 2020 $ 1,402 $ 2,511,849   $ 446,315 $ 51,254 $ (276,886)   $ 2,733,934
Balance (in shares) at Sep. 30, 2020 129,911,789             129,911,789